Berkeley Heights, NJ - May 17, 2005-
Genta Incorporated (Nasdaq: GNTA) will host a conference call and
live audio webcast to discuss its first quarter financial results,
along with data presented during the annual meeting of the American
Society of Clinical Oncology (ASCO) on Wednesday, May 18, 2005.
Genta management will host the conference call and live audio
webcast at 8:30 AM EDT.
The conference call can be accessed live as follows:
U.S./Canada: Dial (877) 634-8606, reference Genta Incorporated.
International: Dial (706) 679-3140, reference Genta
Incorporated.
The webcast will be available in the Investor Relations section
of the Company's website at:
http://www.genta.com/genta/InvestorRelation/events.html
and will be archived for 30 days. Audio replay will be available
approximately two hours after the completion of the call, and will
be archived for 30 days. Access numbers for this replay are: (800)
642- 1687 (U.S./Canada) and (706) 645-9291 (International);
conference ID number is 5958560.
About Genta
Genta Incorporated is a biopharmaceutical company with a
diversified product portfolio that is focused on delivering
innovative products for the treatment of patients with cancer. The
Company's research platform is anchored by two major programs that
center on oligonucleotides (RNA and DNA-based medicines) and small
molecules. Genasense® (oblimersen sodium) Injection, the Company's
lead compound from its oligonucleotide program is currently
undergoing late-stage, Phase 3 clinical testing. The leading drug
in Genta's small molecule program is Ganite® (gallium nitrate
injection), which the Company is exclusively marketing in the U.S.
for treatment of patients with cancerrelated hypercalcemia that is
resistant to hydration. For more information about Genta, please
visit our website at:
http://www.genta.com/
.
This press release and the conference call and webcast to
follow contain forward-looking statements with respect to
business conducted by Genta Incorporated. By their nature,
forward-looking statements and forecasts involve risks and
uncertainties because they relate to events and depend on
circumstances that will occur in the future. There are a number
of factors that could cause actual results and developments to
differ materially. For a discussion of those risks and
uncertainties, please see the Company's Annual Report/Form 10-K
for 2004.
SOURCE: Genta Incorporated
